Hypercoagulopathy in COVID-19, Deep Venous Thrombosis After Extra-Corporeal Membrane Oxygenation Therapy: A Case...

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel coronavirus that has caused a pandemic across the world in the years 2019 - 2020 with over 100 countries reporting high infection rates. The virus is unique in the wide spectrum of disease manifestations it can cause; one of the worst of which is the hypercoagulable state induced by severe infection. This case report focuses on a 33-year-old Hispanic male who developed severe acute respiratory syndrome requiring management with extracorporeal membrane oxygenation (ECMO) and developed deep venous thromboses during severe coronavirus disease 2019 (COVID-19) pneumonia. Since there are no current guideline(s) for routine screening for venous thromboembolism (VTE) in ECMO patients, we aim to highlight a proposed benefit of routine screening for VTE in patients with severe COVID-19 treated with ECMO pre-cannulation and post-decannulation, which minimizes the risk of cannulation-associated complications, as well as the risk of post-decannulation VTE respectively. While VTE is a known complication of ECMO therapy, the rates of increased incidence of VTE in patients with severe COVID-19 make the detection of such complications even more important to reduce overall morbidity and mortality.